Preliminary Detailed Programme
13 October 2023 (Friday) |
|
|
OPENING CEREMONY (Prague B+C)Chair: Fábryová Ľubomíra, Halford Jason |
09:20–09:40 | Fábryová Ľubomíra (Bratislava, Slovakia): Obesity and type 2 diabetes mellitus – inseparable twins? |
09:40–10:00 | Halford Jason (Leeds, UK): Barriers to obesity management for adolescents living with obesity |
10:00–10:20 | Woodward Euan (London, UK): European Policy Update: Opportunities for the Obesity Community |
10:20–10:40 | Grunberger George (Detroit, USA): Technology in treatment of obesity and diabetes: Today and tomorrow. An American perspective |
10:40–11:00 | Vettor Roberto (Padova, Italy): Adipose tissue dysfunction in obesity |
11:00–11:30 | Coffee Break | Commercial Exhibition | Poster Viewing |
11:30–12:30 |
Industry Symposium (Prague B+C) |
12:30–13:15 | Lunch |
13:15–14:45 |
SESSION 1: CHILDHOOD OBESITY (Prague B+C)Chair: Aldhoon Hainerova Irena, Heitmann Berit |
13:15–13:45 | Heitmann Berit (Copenhagen, Denmark): Primary prevention of overweight among children – is it possible? |
13:45–14:00 | Aldhoon Hainerova Irena (Prague, Czech Republic): Differential diagnosis of obesity in children: From endocrine disorders to genetic causes of obesity |
14:00–14:15 | Totomirova Tzvetelina (Sofia, Bulgaria): Before screen time assessment is crucial for prediction of body weight problems adolescents |
14:15–14:30 | Nutsubidze Teona (Tbilisi, Georgia): Fatty liver disease in children |
14:30–14:45 | Pastucha Dalibor (Ostrava, Czech Republic): Possibilities of physical activity prescription for children with obesity |
14:45–15:00 | Coffee Break | Commercial Exhibition | Poster Viewing |
13:15–14:45 |
SESSION 2: BARIATRIC SURGERY (Prague A)Chair: Coupaye Muriel, Fried Martin |
13:15–13:45 | Fried Martin (Prague, Czech Republic): New perspectives of bariatric treatment |
13:45–14:00 | Fultang Joshua (Ayr, UK): Long-term type II diabetes (T2DM) remission: Can long-term remission be predicted by only age and insulin use status? |
14:00–14:15 | Fultang Joshua (Ayr, UK): Does preoperative weight loss (POWL) influence type II diabetes remission (T2DM) following bariatric surgery? |
14:15–14:30 | Holéczy Pavol (Ostrava, Czech Republic): Partial jejunal diversion with jejuno-colic anastomosis after initial enthusiasm disappointment |
14:30–14:45 | Šrámková Petra (Prague, Czech Republic): Partial jejunal diversion – a new type of metabolic operation, case reports |
15:00–16:30 |
SESSION 3: DIET AND EXERCISE IN OBESITY MANAGEMENT (Prague B+C)Chair: Kunešová Marie, Ukropcová Barbara |
15:00–15:30 | Ukropcová Barbara (Bratislava, Slovakia): Aerobic-strength training modulates anthropometric parameters, metabolism, cognition and adiponectin levels in cerebrospinal fluid in the elderly |
15:30–15:45 | Slobodová Lucia (Bratislava, Slovakia): Effect of aerobic-strength training and dietary intervention on cognitive performance in obese adults |
15:45–16:00 | Arhire Lidia (Iasi, Romania): Relationship between determinants of food choice and weight |
16:00–16:15 | Bilen Alihan (Istanbul, Turkey): What are the differences between the subgroups? Comparative analysis on stratified levels of obesity |
16:15–16:30 | Selinger Eliška (Prague, Czech Republic): Nutritional Health in Czechia: Overview of current status and potential for improvement |
16:30–17:00 | Coffee Break | Commercial Exhibition | Poster Viewing |
15:00–16:30 |
SESSION 4: BONE MARROW ADIPOSE TISSUE & MICROBIOTA (Prague A)Chair: Tencerova Michaela, Vettor Roberto |
15:00–15:30 | Tencerova Michaela (Prague, Czech Republic): Bone marrow adipose tissue under control of nutrient sensors |
15:30–15:45 | Džubanová Martina (Prague, Czech Republic): NOX4 deletion decreased fat mass and diminished bone marrow adiposity in animal model of obesity |
15:45–16:00 | Zavaďáková Anna (Pilsen, Czech Republic): A broader context of obesity and other non-communicable diseases pandemic: focused on the gut microbiome |
16:00–16:15 | Nechalová Libuša (Bratislava, Slovakia): Probiotics and Exercise: Which Affects More the Gut Microbiome in Context of Human Health and Obesity? |
16:15–16:30 | Taxová-Braunerová Radka (Prague, Czech Republic): Sleep disruption and obesity |
17:00–18:15 |
SESSION 5: NEUROLOGICAL AND PSYCHOBEHAVIORAL ASPECTS OF OBESITY (Prague B+C)Chair: Olszanecka-Glinianowicz Magdalena, Ukropec Jozef |
17:00–17:30 | Olszanecka-Glinianowicz Magdalena (Warsaw, Poland): The role of emotional eating in the development of obesity |
17:30–17:45 | Ukropec Jozef (Bratislava, Slovakia): Common pathomechanisms of metabolic and neurodegenerative diseases: the impact of regular exercise in patients with Parkinson disease |
17:45–18:00 | Málková Iva (Prague, Czech Republic): 40 years of experience of applying CBT in the prevention and treatment of obesity in the Czech Republic |
18:00–18:15 | Majerčák Ivan (Košice, Slovakia): Cognitive-behavioural intervention in obesity management STOp Obesity |
17:00–18:30 |
SESSION 6: NONSHIVERING THERMOGENESIS & SYSTEMIC METABOLISM (Prague A)Chair: Kopecký Jan, Zouhar Petr |
17:00–17:30 | Kopecký Jan (Prague, Czech Republic): Nonshivering thermogenesis in skeletal muscle |
17:30–17:45 | Balaz Miroslav (Bratislava, Slovakia): Lactate promotes protein kinase A signaling and metabolic activity of brown adipocytes |
17:45–18:00 | Zouhar Petr (Prague, Czech Republic): Effects of Fibroblast growth factor 21 (FGF21) on energy expenditure: Mechanism of action |
18:00–18:15 | Bardová Kristina (Prague, Czech Republic): Plasma leptin levels during postnatal surge as a biomarker of body weight gain in mice |
18:15–18:30 | Panzarin Carolina (Limeira, Brazil): VLDLR expression is necessary for increased miR-122 levels in adipose tissue observed in an experimental model of NAFLD |
14 October 2023 (Saturday) |
|
08:30–10:30 |
SESSION 7: PHARMACOTHERAPY AND NOVEL COMBINED APPROACHES (Prague B+C)Chair: Hassapidou Maria, Prager Gerhard |
08:30–08:45 | Laštovková Andrea (Bohumín, Czech Republic): Management of obesity in GP’s office using GLP-1 agonists |
08:45–09:00 | Seier Søren (Copenhagen, Denmark): Engaging through the online Embla solution to reduce body weight and achieve clinically relevant endgoals (EMBRACE). |
09:00–09:15 | Haluzík Martin (Prague, Czech Republic): The comprehensive approach towards research and treatment of obesity, type 2 diabetes and cardiovascular complications: The CarDia project |
09:15–09:30 | Müllerová Dana (Pilsen, Czech Republic): Management of obesity, yesterday, today, and tomorrow |
09:30–10:00 | Hassapidou Maria (Athens, Greece): European Dietary guidelines for the Medical Nutrition Therapy (MNT) of adults and children with obesity |
10:00–10:30 | Prager Gerhard (Wien, Austria): Metabolic-bariatric surgery beyond pure weight loss: The most effective treatment of the Metabolic Syndrome? |
10:30–11:00 | Coffee Break | Commercial Exhibition | Poster Viewing |
11:00–12:00 |
SESSION 8: PREVENTION (Prague B+C)Chair: Hainer Vojtěch, Halmy Eszter |
11:00–11:15 | Halmy Eszter (Budapest, Hungary): The obesity related mortality in COVID-19 and the effect of COVID-19 pandemic on the recent trends of obesity in Hungary |
11:15–11:30 | Rurik Imre (Budapest, Hungary): The prevalence and economic burden of obesity in Hungary |
11:30–11:45 | Alrowaily Mohammed (Riyadh, Saudi Arabia): Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic in Saudi Arabia |
11:45–12:00 | Mrázová Mariana (Bratislava, Slovakia): Risk factors of obesity in V4 countries a survey of Institute for Prevention and intervention |
12:00–13:00 |
MIDDLE REGION PRESIDENTS ROUND TABLE & CLOSING CEREMONY (Prague B+C)Chair: Ľubomíra Fábryová, Dana Müllerová (present and past Vice-Presidents Middle Region of EASO) |
Slovak Obesity Association Czech Society for the Study of Obesity Austrian Obesity Association Croatian Obesity Association Association Francaise d'Etudes et de Recherches sur l'Obesite Georgian Association for the Study of Obesity Hungarian Society for the Study of Obesity Polish Association for the Study of Obesity Romanian Association for the Study of Obesity Professional Section of the Slovenian Association for Obesity ECPO and national councils of patients living with obesity |
Programme changes reserved.
Last update on 2 October 2023.